Latest stories on YARW
Yarrow Bioscience, Inc. (YARW) files 8-K
SEC 8-K50 · neutralgeneral
Yarrow Bioscience prices $150M public offering of common stock at $26 per share
Seeking Alpha28 · bearishgeneral
Yarrow Bioscience 5.77M share Spot Secondary priced at $26.00
The Fly28 · bearishgeneral
Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering
StockTitan24 · bearishgeneral
Yarrow Bioscience Updates Strategy for Thyroid Autoimmune Pipeline
TipRanks56 · neutralproduct/pr
Yarrow Bioscience announces proposed public offering
Seeking Alpha24 · bearishgeneral
Yarrow Bioscience announces common stock offering, no amount given
The Fly28 · bearishgeneral
Yarrow Bioscience Announces Proposed Underwritten Public Offering
StockTitan28 · bearishgeneral
Yarrow Bioscience, Inc. (YARW) files 8-K
SEC 8-K50 · neutralgeneral
Yarrow Bioscience reported Q2 EPS ($2.14)
The Fly44 · neutralearnings
8-K/A - Yarrow Bioscience, Inc. (VYNE) files 8-K
SEC 8-K50 · neutralgeneral
Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update
StockTitan52 · neutralgeneral
Yarrow Bioscience, Inc. (VYNE) files 8-K
SEC 8-K50 · neutralgeneral
VYNE Announces Reverse Stock Split and Special Dividend Ahead of Yarrow Bioscience Merger
MarketChameleon28 · bearishgeneral
VYNE Therapeutics approves 1-for-50 reverse stock split ahead of Yarrow merger
Seeking Alpha25 · bearishgeneral
VYNE Therapeutics declares $0.38/share merger-contingent special dividend
Seeking Alpha50 · neutralgeneral
VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience
Business Insider55 · neutralm&a
VYNE Highlights Yarrow Merger Strategy and Endocrine Pipeline
TipRanks56 · neutralgeneral